alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › intravenous

intravenous

3 studies tagged intravenous, dated 2008-02-21 to 2025-01-16. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Targeting Soluble Amyloid Oligomers in Alzheimer's Disease: A Hypothetical Model Study Comparing Intrathecal Pseudodelivery of mAbs Against Intravenous Administration 2025-01-16
  2. Intravenous immunoglobulins for Alzheimer's disease and mild cognitive impairment due to Alzheimer's disease: A systematic review with meta-analysis 2019-05-23
  3. 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease 2008-02-21

Studies

3 studies carry this tag.

Date range

2008 to 2025

Top journals

  • Diseases (Basel, Switzerland) 1
  • Expert review of neurotherapeutics 1
  • Neurobiology of aging 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Targeting Soluble Amyloid Oligomers in Alzheimer's Disease: A Hypothetical Model Study Comparing Intrathecal Pseudodelivery of mAbs Against Intravenous Administration

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Diseases (Basel, Switzerland) 2025-01-16 Treatments

    Intrathecal pseudodelivery offers a promising alternative to IV mAbs, overcoming challenges associated with blood-brain barrier penetration and systemic side effects.

  2. Intravenous immunoglobulins for Alzheimer's disease and mild cognitive impairment due to Alzheimer's disease: A systematic review with meta-analysis

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Expert review of neurotherapeutics 2019-05-23 Drug development

    Expert opinion : No significant differences were found in the scores of mini-mental state examination and Alzheimer's disease assessment scale-cognitive subscale and number of patients with adverse events.

  3. 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Neurobiology of aging 2008-02-21 Tau biomarkers

    Intravenous immunoglobulin (IVIg) has been proposed as a potential agent for Alzheimer's disease (AD) immunotherapy because it contains antibodies against beta-amyloid (Abeta).

All topic tags with their study counts